Extracted from one of the last posts of niu (referring about what we can read in the next quarterly report):
We will see some comment around the Bateman LiOH study. Given that they have dropped significantly off the originally announced timeline, I am expecting a "discontinued" comment. Not unduly concerned - phase 2 seems a lower risk path and the go it alone path always had something of the feel of a negotiating ploy. Either way, it requires a comment.
As everybody knows here all what niu writes is 100% true so surely in the next quarterly report it will be mentioning something about this.
ORE Price at posting:
$4.61 Sentiment: None Disclosure: Not Held
